AMGEN
About Amgen
Science
Corporate Citizenship
Sitemap
Search
Privacy & Terms
Contact Us
Patients
Medical Professionals
Partners
Investors
Careers
Media
read more
Dec 16 /
Oncology Biomarker KRAS to be Discussed at FDA Panel...
Dec 8 /
Long-term Follow Up Interim Data Show Nplate(TM)...
Nov 21 /
Nplate(TM) (Romiplostim) Receives Positive Opinion...
Nov 19 /
Amgen, Takeda and Millennium Provide Update on Phase...
Featured Links
Amgen Tour of California
Breakaway From Cancer
© 2000-2005 Amgen Inc. All Rights Reserved.